After launching four venture-backed, single-product companies that all made it to market in 18 months or less with modest amounts of capital, two surgeons-turned-entrepreneurs have transitioned their business to a multi-product, public medical device company. New York-based Pavmed Inc. (NASDAQ: PAVMU) made its public debut late last week with an initial public offering of 1,060,000 units. Read More
